ProfileGDS5822 / ILMN_1230794
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 24% 50% 42% 25% 30% 25% 6% 12% 13% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 113.924
GSM1276600PDAC Late Ablation Control 224.450
GSM1276601PDAC Late Ablation Control 315.142
GSM1276602PDAC Late Ablation 112.525
GSM1276603PDAC Late Ablation 215.230
GSM1276604PDAC Late Ablation 313.625
GSM1303940PDAC Late Ablation_anti-CTLA4 17.56
GSM1303941PDAC Late Ablation_anti-CTLA4 27.612
GSM1303942PDAC Late Ablation_anti-CTLA4 37.713